SalpeterSR, BuckleyJS, BrueraE. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med, 2013; 16:616–622.
2.
ChuLF, AngstMS, ClarkD. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain, 2008; 24:479–496.
AndrewsHL. The effect of opiates on the pain threshold in post-addicts. J Clin Invest, 1943; 22:511–516.
5.
ComptonP, CharuvastraVC, LingW. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug Alcohol Depend, 2001; 63:139–146.
6.
TreisterR, EisenbergE, LawentalE, PudD. Is opioid-induced hyperalgesia reversible? A study on active and former opioid addicts and drug naive controls. J Opioid Manag, 2012; 8:343–349.
ChuLF, ClarkDJ, AngstMS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain, 2006; 7:43–48.
9.
HootenWM, MantillaCB, SandroniP, TownsendCO. Associations between heat pain perception and opioid dose among patients with chronic pain undergoing opioid tapering. Pain Med, 2010; 11:1587–1598.
10.
BaronMJ, McDonaldPW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag, 2006; 2:277–282.
11.
HoltmanJRJr., JellishWS. Opioid-induced hyperalgesia and burn pain. J Burn Care Res, 2012; 33:692–701.
MaltbieAA, CavenarJOJr., SullivanJL, HammettEB. Haloperidol treatment of a sixty-year narcotic addiction: Case report. Military Med, 1979; 144:251–252.
14.
DawJL, Cohen-ColeSA. Haloperidol analgesia. South Med J, 1981; 74:364–365.
15.
MaltbieAA, CavenarJOJr.Haloperidol and analgesia: Case reports. Military Med, 1977; 142:946–948.
